A smartphone app for self-directed upper limb therapy after stroke
Feasibility and Effectiveness of AI-powered Interactive Smartphone Application for a Self-directed Upper Limb Therapy Implementation After Stroke
NA · Tan Tock Seng Hospital · NCT06190795
This study is testing whether a smartphone app can help stroke patients do their upper limb therapy on their own and see if it works better than using a printed manual.
Quick facts
| Phase | NA |
|---|---|
| Study type | Interventional |
| Enrollment | 80 (estimated) |
| Ages | 21 Years to 90 Years |
| Sex | All |
| Sponsor | Tan Tock Seng Hospital (other) |
| Locations | 1 site (Singapore) |
| Trial ID | NCT06190795 on ClinicalTrials.gov |
What this trial studies
This study investigates the feasibility and effectiveness of an AI-powered smartphone application called AMPLIFY for self-directed upper limb therapy in stroke patients. Participants, within four weeks post-stroke, will be randomly assigned to either use the smartphone app or a hardcopy manual for a four-week therapy program. The study aims to enhance adherence and improve recovery outcomes by providing immediate feedback and reminders through the app. Assessments will be conducted at three time points to evaluate the clinical effects of both delivery methods.
Who should consider this trial
Good fit: Ideal candidates are individuals diagnosed with stroke within four weeks of onset, with sufficient cognitive function and upper limb mobility.
Not a fit: Patients with bilateral strokes, severe cognitive impairment, or significant pre-existing upper limb issues may not benefit from this study.
Why it matters
Potential benefit: If successful, this approach could significantly improve upper limb recovery and adherence to therapy in stroke patients.
How similar studies have performed: Other studies have shown promise in using technology for rehabilitation, but this specific approach with an AI smartphone app is relatively novel.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Diagnosis of stroke (confirmed by CT/MRI scans) * ≤four weeks post-stroke * Montreal Cognitive Assessment (MOCA)\>=21 * Finger extension Medical Research Council (MRC) \>=1 * Fugl Meyer Upper Limb score \<60 or NIHSS Motor Arm section score\>=2 * Potential discharge to home (able to do tele-rehabilitation for review) Exclusion Criteria: * Bilateral stroke * Montreal Cognitive Assessment (MOCA)\<21 * Paretic upper limb numeric pain rating scale (NPRS)\>5 * Reduced paretic upper limb use prior to stroke episode (e.g. frozen shoulder, fracture, etc) * Reduced paretic upper limb use due to orthopaedic problems such as fracture in existing stroke episode * Medically unstable * Neglect as ascertained by treatment team * Severe behavioural disturbance or agitation or epilepsy or untreated depression or psychiatric conditions * Pregnancy or lactation states
Where this trial is running
Singapore
- Lay Fong Chin — Singapore, Singapore (RECRUITING)
Study contacts
- Study coordinator: Lay Fong Chin, PhD
- Email: lay_fong_chin@ttsh.com.sg
- Phone: +6568435896
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: Stroke, Upper Limb, Therapy